These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 17331488

  • 1. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
    Boffa MB, Koschinsky ML.
    Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
    [Abstract] [Full Text] [Related]

  • 2. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J, Hudecek J, Kubisz P.
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM, Cooper AJ, Lwaleed BA.
    Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
    [Abstract] [Full Text] [Related]

  • 4. [The TAFI system. The new role of fibrinolysis].
    Dempfle CE.
    Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
    [Abstract] [Full Text] [Related]

  • 5. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L.
    Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
    [Abstract] [Full Text] [Related]

  • 6. An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma.
    Kim PY, Foley J, Hsu G, Kim PY, Nesheim ME.
    Anal Biochem; 2008 Jan 01; 372(1):32-40. PubMed ID: 17967438
    [Abstract] [Full Text] [Related]

  • 7. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO, Bouma BN.
    Arterioscler Thromb Vasc Biol; 2006 Nov 01; 26(11):2445-53. PubMed ID: 16960106
    [Abstract] [Full Text] [Related]

  • 8. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1998 Nov 01; 80(5):829-35. PubMed ID: 9843179
    [Abstract] [Full Text] [Related]

  • 9. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N, Guldiken S, Demir M, Tugrul A.
    Clin Appl Thromb Hemost; 2010 Oct 01; 16(5):568-73. PubMed ID: 19959491
    [Abstract] [Full Text] [Related]

  • 10. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN, Mosnier LO.
    Ann Med; 2006 Oct 01; 38(6):378-88. PubMed ID: 17008302
    [Abstract] [Full Text] [Related]

  • 11. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P.
    Hepatology; 2003 Jul 01; 38(1):230-7. PubMed ID: 12830006
    [Abstract] [Full Text] [Related]

  • 12. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 01; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 13. A functional assay for measuring activated thrombin-activatable fibrinolysis inhibitor in plasma.
    Neill EK, Stewart RJ, Schneider MM, Nesheim ME.
    Anal Biochem; 2004 Jul 15; 330(2):332-41. PubMed ID: 15203340
    [Abstract] [Full Text] [Related]

  • 14. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct 15; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 15. Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation.
    Colucci M, Semeraro N.
    Thromb Res; 2012 Mar 15; 129(3):314-9. PubMed ID: 22113149
    [Abstract] [Full Text] [Related]

  • 16. Myocardial infarction and the balance between fibrin deposition and removal.
    Nesheim M.
    Ital Heart J; 2001 Sep 15; 2(9):641-5. PubMed ID: 11666089
    [Abstract] [Full Text] [Related]

  • 17. Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor.
    Buelens K, Hillmayer K, Compernolle G, Declerck PJ, Gils A.
    Circ Res; 2008 Feb 15; 102(3):295-301. PubMed ID: 18063813
    [Abstract] [Full Text] [Related]

  • 18. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG, Steenwyk BL, Gurley WQ.
    J Heart Lung Transplant; 2006 Oct 15; 25(10):1247-52. PubMed ID: 17045938
    [Abstract] [Full Text] [Related]

  • 19. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
    Mosnier LO, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct 15; 86(4):1040-6. PubMed ID: 11686322
    [Abstract] [Full Text] [Related]

  • 20. [Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients].
    Kemona-Chetnik I, Kowal K, Kucharewicz I, Pampuch A, Bodzenta-Lukaszyk A.
    Przegl Lek; 2006 Oct 15; 63(12):1281-5. PubMed ID: 17642140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.